269 related articles for article (PubMed ID: 21810913)
1. Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression.
Noman MZ; Janji B; Kaminska B; Van Moer K; Pierson S; Przanowski P; Buart S; Berchem G; Romero P; Mami-Chouaib F; Chouaib S
Cancer Res; 2011 Sep; 71(18):5976-86. PubMed ID: 21810913
[TBL] [Abstract][Full Text] [Related]
2. The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis.
Noman MZ; Buart S; Van Pelt J; Richon C; Hasmim M; Leleu N; Suchorska WM; Jalil A; Lecluse Y; El Hage F; Giuliani M; Pichon C; Azzarone B; Mazure N; Romero P; Mami-Chouaib F; Chouaib S
J Immunol; 2009 Mar; 182(6):3510-21. PubMed ID: 19265129
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced autophagy: a new player in cancer immunotherapy?
Noman MZ; Janji B; Berchem G; Mami-Chouaib F; Chouaib S
Autophagy; 2012 Apr; 8(4):704-6. PubMed ID: 22441015
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-β1.
Hasmim M; Noman MZ; Messai Y; Bordereaux D; Gros G; Baud V; Chouaib S
J Immunol; 2013 Dec; 191(12):5802-6. PubMed ID: 24227785
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-dependent inhibition of tumor cell susceptibility to CTL-mediated lysis involves NANOG induction in target cells.
Hasmim M; Noman MZ; Lauriol J; Benlalam H; Mallavialle A; Rosselli F; Mami-Chouaib F; Alcaide-Loridan C; Chouaib S
J Immunol; 2011 Oct; 187(8):4031-9. PubMed ID: 21911602
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-fusion degradation pathway plays an indispensable role in naked DNA vaccination with a chimeric gene encoding a syngeneic cytotoxic T lymphocyte epitope of melanocyte and green fluorescent protein.
Zhang M; Ishii K; Hisaeda H; Murata S; Chiba T; Tanaka K; Li Y; Obata C; Furue M; Himeno K
Immunology; 2004 Aug; 112(4):567-74. PubMed ID: 15270727
[TBL] [Abstract][Full Text] [Related]
7. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
9. HSF1 stress response pathway regulates autophagy receptor SQSTM1/p62-associated proteostasis.
Watanabe Y; Tsujimura A; Taguchi K; Tanaka M
Autophagy; 2017 Jan; 13(1):133-148. PubMed ID: 27846364
[TBL] [Abstract][Full Text] [Related]
10. Autophagic degradation of the androgen receptor mediated by increased phosphorylation of p62 suppresses apoptosis in hypoxia.
Mitani T; Minami M; Harada N; Ashida H; Yamaji R
Cell Signal; 2015 Oct; 27(10):1994-2001. PubMed ID: 26186973
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62.
Pursiheimo JP; Rantanen K; Heikkinen PT; Johansen T; Jaakkola PM
Oncogene; 2009 Jan; 28(3):334-44. PubMed ID: 18931699
[TBL] [Abstract][Full Text] [Related]
12. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.
Barsoum IB; Smallwood CA; Siemens DR; Graham CH
Cancer Res; 2014 Feb; 74(3):665-74. PubMed ID: 24336068
[TBL] [Abstract][Full Text] [Related]
13. [Xenogeneic melanoma-related antigen elicits anti-tumor immune response, companied by autoimmune injury].
Tan XH; Wan YH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1596-600. PubMed ID: 16185524
[TBL] [Abstract][Full Text] [Related]
14. Autophagy inhibition promotes defective neosynthesized proteins storage in ALIS, and induces redirection toward proteasome processing and MHCI-restricted presentation.
Wenger T; Terawaki S; Camosseto V; Abdelrassoul R; Mies A; Catalan N; Claudio N; Clavarino G; de Gassart A; Rigotti Fde A; Gatti E; Pierre P
Autophagy; 2012 Mar; 8(3):350-63. PubMed ID: 22377621
[TBL] [Abstract][Full Text] [Related]
15. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
[TBL] [Abstract][Full Text] [Related]
16. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
Böhm W; Thoma S; Leithäuser F; Möller P; Schirmbeck R; Reimann J
J Immunol; 1998 Jul; 161(2):897-908. PubMed ID: 9670968
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-Induced Caveolin-1 Expression Promotes Migration and Invasion of Tumor Cells.
Castillo Bennett J; Silva P; Martinez S; Torres VA; Quest AFG
Curr Mol Med; 2018; 18(4):199-206. PubMed ID: 30259813
[TBL] [Abstract][Full Text] [Related]
18. Innate and adoptive immune cells contribute to natural resistance to systemic metastasis of B16 melanoma.
Umeshappa CS; Zhu Y; Bhanumathy KK; Omabe M; Chibbar R; Xiang J
Cancer Biother Radiopharm; 2015 Mar; 30(2):72-8. PubMed ID: 25714591
[TBL] [Abstract][Full Text] [Related]
19. [Effects of STAT3 antisense oligodeoxynucleotides on apoptosis and proliferation of mouse melanoma cell line B16].
Tang GS; Cai JM; Ni J; Xiang YS; Cui JG; Zhu D; Dong JR
Ai Zheng; 2006 Mar; 25(3):269-74. PubMed ID: 16536977
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocytes block tumor growth both by lytic activity and IFNγ-dependent cell-cycle arrest.
Matsushita H; Hosoi A; Ueha S; Abe J; Fujieda N; Tomura M; Maekawa R; Matsushima K; Ohara O; Kakimi K
Cancer Immunol Res; 2015 Jan; 3(1):26-36. PubMed ID: 25127875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
